. Altered neuronal enpathological function that disrupts an essential celluergy metabolism was reported in HD, but these changes lar process and leads to loss of affected neurons. Asmay be secondary to pathology and do not explain sesociation of huntingtin with vesicular structures raised lective neuronal vulnerability. Excitotoxicity was also the possibility that axonal transport might be altered.
show percentages of cells ures 5A, 5D, and 5F). In contrast, perfusion of compara- Cell-specific differences in these essential pathways may lead to lower thresholds for some neuronal populations than others. For example, limiting levels of neurotrophins supplied by neuronal targets may increase vulnerability in a given neuronal population, or there may be differences in ratios of pathogenic polypeptide to neuronal target proteins. Similar arguments were invoked to explain why the largest and/or longest neurons are particularly vulnerable in toxic neuropathies and models of amyotrophic lateral sclerosis (Brady, 1995).
Kinesin-and dynein-based motility of membrane bounded organelles is highly conserved across species. Inhibition of fast axonal transport in isolated axoplasm and of neurite extension in mammalian neuronal cell lines by polypeptides containing pathogenic polyglutamine expansions are consistent with a common mechanism. Ideally, these studies will be extended to transgenic mouse models for glutamine expansion diseases. However, misexpression of proteins, particularly overexpression, may produce pathologies distinct from the polyglutamine expansion pathway (i.e., see Szebenyi et al., 2002). Late onset for neuronal degeneration in polyglutamine expansion diseases suggests that transport defects may be subtle prior to onset of symptoms, particularly in neurons slow to exhibit pathology. Based on observations presented here, we expect the amount of kinesin-and/or dynein-transported cargos in the terminals to be affected and average transport rates to be 
